aluates Reports

$ 0.0

Automative

Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Research Report 2024

Published Date: January 2025

Report Code: QYRE-Auto-1Z18907

BUY CHAPTERS

Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Research Report 2024

Code: QYRE-Auto-1Z18907

Report

January 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

WuXi AppTec

Syngene International Limited

Charles River Laboratories

Aurigene Pharmaceutical Services Ltd.

Boc Sciences

BPS Bioscience

Bio-Techne

Apeloa Pharmaceutical Co.,Ltd.

Creative-Biolabs

Veranova, L.P.

Aganitha AI Inc.

Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size

The global market for Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services was valued at US$ 445 million in the year 2023 and is projected to reach a revised size of US$ 866 million by 2030, growing at a CAGR of 9.8% during the forecast period.

Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market

Proteolysis Targeting Chimeras (PROTACs) are a series of hetero-bifunctional molecules that hijack the body’s own natural disposal system to initiate selective degradation of the protein of interest (POI). PROTACs have the potential to overcome most of the limitations of small molecule inhibitors, and they offer several advantages of the traditional concepts of drug discovery.

North American market for Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services in Targeted Protein Degradation is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services include WuXi AppTec, Syngene International Limited, Charles River Laboratories, Veranova, L.P., Aurigene Pharmaceutical Services Ltd, BOC Sciences, BPS Bioscience, Bio-Techne, Apeloa Pharmaceutical Co. Ltd., Aganitha AI Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services.

The Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Report

Report Metric	Details
Report Name	Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market
Accounted market size in year	US$ 445 million
Forecasted market size in 2030	US$ 866 million
CAGR	9.8%
Base Year	year
Forecasted years	2025 - 2030
Segment by Type	PROTACs Targeting Protein Kinases PROTACs Targeting Nuclear Receptors PROTACs Targeting BET Proteins PROTACs Targeting Additional Protein
Segment by Application	Targeted Protein Degradation Drug Discovery Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	WuXi AppTec, Syngene International Limited, Charles River Laboratories, Veranova, L.P., Aurigene Pharmaceutical Services Ltd, BOC Sciences, BPS Bioscience, Bio-Techne, Apeloa Pharmaceutical Co. Ltd., Aganitha AI Inc., Creative Biolabs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market growing?

Ans: The Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market witnessing a CAGR of 9.8% during the forecast period 2025-2030.

What is the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market size in 2030?

Ans: The Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market size in 2030 will be US$ 866 million.

Who are the main players in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report?

Ans: The main players in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market are WuXi AppTec, Syngene International Limited, Charles River Laboratories, Veranova, L.P., Aurigene Pharmaceutical Services Ltd, BOC Sciences, BPS Bioscience, Bio-Techne, Apeloa Pharmaceutical Co. Ltd., Aganitha AI Inc., Creative Biolabs

What are the Application segmentation covered in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report?

Ans: The Applications covered in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report are Targeted Protein Degradation, Drug Discovery, Other

What are the Type segmentation covered in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report?

Ans: The Types covered in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report are PROTACs Targeting Protein Kinases, PROTACs Targeting Nuclear Receptors, PROTACs Targeting BET Proteins, PROTACs Targeting Additional Protein

Recommended Reports

Protein Targeted Therapeutics

Biopharma Manufacturing

Cell and Gene Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 PROTACs Targeting Protein Kinases

1.2.3 PROTACs Targeting Nuclear Receptors

1.2.4 PROTACs Targeting BET Proteins

1.2.5 PROTACs Targeting Additional Protein

1.3 Market by Application

1.3.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Targeted Protein Degradation

1.3.3 Drug Discovery

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Perspective (2019-2030)

2.2 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Growth Trends by Region

2.2.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Historic Market Size by Region (2019-2024)

2.2.3 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Region (2025-2030)

2.3 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Dynamics

2.3.1 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Industry Trends

2.3.2 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Drivers

2.3.3 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Challenges

2.3.4 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Players by Revenue

3.1.1 Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Players by Revenue (2019-2024)

3.1.2 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Players (2019-2024)

3.2 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue

3.4 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Concentration Ratio

3.4.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue in 2023

3.5 Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Head office and Area Served

3.6 Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Product and Application

3.7 Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Breakdown Data by Type

4.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Historic Market Size by Type (2019-2024)

4.2 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Type (2025-2030)

5 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Breakdown Data by Application

5.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Historic Market Size by Application (2019-2024)

5.2 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2019-2030)

6.2 North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2019-2024)

6.4 North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2019-2030)

7.2 Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2019-2024)

7.4 Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2019-2030)

8.2 Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (2019-2024)

8.4 Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2019-2030)

9.2 Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2019-2024)

9.4 Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2019-2030)

10.2 Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2019-2024)

10.4 Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 WuXi AppTec

11.1.1 WuXi AppTec Company Details

11.1.2 WuXi AppTec Business Overview

11.1.3 WuXi AppTec Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.1.4 WuXi AppTec Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.1.5 WuXi AppTec Recent Development

11.2 Syngene International Limited

11.2.1 Syngene International Limited Company Details

11.2.2 Syngene International Limited Business Overview

11.2.3 Syngene International Limited Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.2.4 Syngene International Limited Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.2.5 Syngene International Limited Recent Development

11.3 Charles River Laboratories

11.3.1 Charles River Laboratories Company Details

11.3.2 Charles River Laboratories Business Overview

11.3.3 Charles River Laboratories Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.3.4 Charles River Laboratories Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.3.5 Charles River Laboratories Recent Development

11.4 Veranova, L.P.

11.4.1 Veranova, L.P. Company Details

11.4.2 Veranova, L.P. Business Overview

11.4.3 Veranova, L.P. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.4.4 Veranova, L.P. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.4.5 Veranova, L.P. Recent Development

11.5 Aurigene Pharmaceutical Services Ltd

11.5.1 Aurigene Pharmaceutical Services Ltd Company Details

11.5.2 Aurigene Pharmaceutical Services Ltd Business Overview

11.5.3 Aurigene Pharmaceutical Services Ltd Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.5.4 Aurigene Pharmaceutical Services Ltd Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.5.5 Aurigene Pharmaceutical Services Ltd Recent Development

11.6 BOC Sciences

11.6.1 BOC Sciences Company Details

11.6.2 BOC Sciences Business Overview

11.6.3 BOC Sciences Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.6.4 BOC Sciences Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.6.5 BOC Sciences Recent Development

11.7 BPS Bioscience

11.7.1 BPS Bioscience Company Details

11.7.2 BPS Bioscience Business Overview

11.7.3 BPS Bioscience Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.7.4 BPS Bioscience Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.7.5 BPS Bioscience Recent Development

11.8 Bio-Techne

11.8.1 Bio-Techne Company Details

11.8.2 Bio-Techne Business Overview

11.8.3 Bio-Techne Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.8.4 Bio-Techne Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.8.5 Bio-Techne Recent Development

11.9 Apeloa Pharmaceutical Co. Ltd.

11.9.1 Apeloa Pharmaceutical Co. Ltd. Company Details

11.9.2 Apeloa Pharmaceutical Co. Ltd. Business Overview

11.9.3 Apeloa Pharmaceutical Co. Ltd. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.9.4 Apeloa Pharmaceutical Co. Ltd. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.9.5 Apeloa Pharmaceutical Co. Ltd. Recent Development

11.10 Aganitha AI Inc.

11.10.1 Aganitha AI Inc. Company Details

11.10.2 Aganitha AI Inc. Business Overview

11.10.3 Aganitha AI Inc. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.10.4 Aganitha AI Inc. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.10.5 Aganitha AI Inc. Recent Development

11.11 Creative Biolabs

11.11.1 Creative Biolabs Company Details

11.11.2 Creative Biolabs Business Overview

11.11.3 Creative Biolabs Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.11.4 Creative Biolabs Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

11.11.5 Creative Biolabs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

WuXi AppTec

Syngene International Limited

Charles River Laboratories

Aurigene Pharmaceutical Services Ltd.

Boc Sciences

BPS Bioscience

Bio-Techne

Apeloa Pharmaceutical Co.,Ltd.

Creative-Biolabs

Veranova, L.P.

Aganitha AI Inc.

List of Tables

Table 1. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of PROTACs Targeting Protein Kinases

Table 3. Key Players of PROTACs Targeting Nuclear Receptors

Table 4. Key Players of PROTACs Targeting BET Proteins

Table 5. Key Players of PROTACs Targeting Additional Protein

Table 6. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Region (2019-2024)

Table 10. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Region (2025-2030)

Table 12. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Trends

Table 13. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Drivers

Table 14. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Challenges

Table 15. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Restraints

Table 16. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Players (2019-2024)

Table 18. Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services as of 2023)

Table 19. Ranking of Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Headquarters and Area Served

Table 22. Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Product and Application

Table 23. Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Type (2019-2024)

Table 27. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Type (2025-2030)

Table 29. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Application (2019-2024)

Table 31. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Application (2025-2030)

Table 33. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2025-2030) & (US$ Million)

Table 48. WuXi AppTec Company Details

Table 49. WuXi AppTec Business Overview

Table 50. WuXi AppTec Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 51. WuXi AppTec Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 52. WuXi AppTec Recent Development

Table 53. Syngene International Limited Company Details

Table 54. Syngene International Limited Business Overview

Table 55. Syngene International Limited Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 56. Syngene International Limited Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 57. Syngene International Limited Recent Development

Table 58. Charles River Laboratories Company Details

Table 59. Charles River Laboratories Business Overview

Table 60. Charles River Laboratories Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 61. Charles River Laboratories Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 62. Charles River Laboratories Recent Development

Table 63. Veranova, L.P. Company Details

Table 64. Veranova, L.P. Business Overview

Table 65. Veranova, L.P. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 66. Veranova, L.P. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 67. Veranova, L.P. Recent Development

Table 68. Aurigene Pharmaceutical Services Ltd Company Details

Table 69. Aurigene Pharmaceutical Services Ltd Business Overview

Table 70. Aurigene Pharmaceutical Services Ltd Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 71. Aurigene Pharmaceutical Services Ltd Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 72. Aurigene Pharmaceutical Services Ltd Recent Development

Table 73. BOC Sciences Company Details

Table 74. BOC Sciences Business Overview

Table 75. BOC Sciences Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 76. BOC Sciences Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 77. BOC Sciences Recent Development

Table 78. BPS Bioscience Company Details

Table 79. BPS Bioscience Business Overview

Table 80. BPS Bioscience Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 81. BPS Bioscience Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 82. BPS Bioscience Recent Development

Table 83. Bio-Techne Company Details

Table 84. Bio-Techne Business Overview

Table 85. Bio-Techne Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 86. Bio-Techne Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 87. Bio-Techne Recent Development

Table 88. Apeloa Pharmaceutical Co. Ltd. Company Details

Table 89. Apeloa Pharmaceutical Co. Ltd. Business Overview

Table 90. Apeloa Pharmaceutical Co. Ltd. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 91. Apeloa Pharmaceutical Co. Ltd. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 92. Apeloa Pharmaceutical Co. Ltd. Recent Development

Table 93. Aganitha AI Inc. Company Details

Table 94. Aganitha AI Inc. Business Overview

Table 95. Aganitha AI Inc. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 96. Aganitha AI Inc. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 97. Aganitha AI Inc. Recent Development

Table 98. Creative Biolabs Company Details

Table 99. Creative Biolabs Business Overview

Table 100. Creative Biolabs Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 101. Creative Biolabs Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024) & (US$ Million)

Table 102. Creative Biolabs Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Picture

Figure 2. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Type: 2023 VS 2030

Figure 4. PROTACs Targeting Protein Kinases Features

Figure 5. PROTACs Targeting Nuclear Receptors Features

Figure 6. PROTACs Targeting BET Proteins Features

Figure 7. PROTACs Targeting Additional Protein Features

Figure 8. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Application (2024-2030) & (US$ Million)

Figure 9. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Application: 2023 VS 2030

Figure 10. Targeted Protein Degradation Case Studies

Figure 11. Drug Discovery Case Studies

Figure 12. Other Case Studies

Figure 13. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Report Years Considered

Figure 14. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Region: 2023 VS 2030

Figure 17. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Players in 2023

Figure 18. Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue in 2023

Figure 20. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Country (2019-2030)

Figure 22. United States Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Country (2019-2030)

Figure 26. Germany Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Region (2019-2030)

Figure 34. China Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Country (2019-2030)

Figure 42. Mexico Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Country (2019-2030)

Figure 46. Turkey Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. UAE Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. WuXi AppTec Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 50. Syngene International Limited Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 51. Charles River Laboratories Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 52. Veranova, L.P. Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 53. Aurigene Pharmaceutical Services Ltd Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 54. BOC Sciences Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 55. BPS Bioscience Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 56. Bio-Techne Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 57. Apeloa Pharmaceutical Co. Ltd. Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 58. Aganitha AI Inc. Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 59. Creative Biolabs Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User